Personalized management of glucokinase-related monogenic diabetes (GCK-MODY) during pregnancy: a case report - Top-Institutions - MDSpire

Personalized management of glucokinase-related monogenic diabetes (GCK-MODY) during pregnancy: a case report

  • By

  • Ana Filipa Bolas

  • João Oliveira Torres

  • Paula Bogalho

  • José Silva-Nunes

  • May 28, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of Exeter Medical School with Royal Devon University Healthcare NHS Foundation Trust
    University of Exeter Medical School with Royal Devon University Healthcare NHS Foundation Trust

    Exeter, England

    Key Differentiators

    • Endocrinology
    • Genetics

  • #2

    University of Chicago Medicine – Kovler Diabetes Center
    University of Chicago Medicine – Kovler Diabetes Center

    Chicago, Illinois

    Key Differentiators

    • Endocrinology
    • Diabetes

  • #3

    Children's Hospital of Nanjing Medical University
    Children's Hospital of Nanjing Medical University

    Nanjing, Jiangsu

    Key Differentiators

    • Pediatrics
    • Endocrinology

  • #4

    Jena University Hospital
    Jena University Hospital

    Jena, Thuringia

    Key Differentiators

    • Obstetrics
    • Endocrinology

  • #5

    Peking Union Medical College Hospital
    Peking Union Medical College Hospital

    Beijing, Beijing

    Key Differentiators

    • Endocrinology
    • Internal Medicine

Original Source(s)

Personalized management of glucokinase-related monogenic diabetes (GCK-MODY) during pregnancy: a case report

  • by Ana Filipa Bolas, João Oliveira Torres, Paula Bogalho, José Silva-Nunes

  • May 28, 2026

Related Content

AACE 2026: Will AI replace endocrinologists?

The same technology drawing patients away from clinic may also improve the patient-physician relationship.

Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy